Latest news
Two new species of oil-forming yeast discovered
A research group has discovered two new species of oil-forming yeast in the soil of Shiga Prefecture in Japan. Their study also examines the relationship between the prefecture’s diverse climate and microbial ecology.
Scientists uncover new pathway of diatom-mediated calcification
Researchers have found that the photosynthesis of a common diatom can induce substantial aragonite precipitation from artificial/natural seawater under significantly lower supersaturation levels required for the precipitation of inorganic CaCO3.
Scientists probe amoeba that thrives at 125°F
Biologists study the mechanisms that have allowed microbial eukaryotes to thrive in the extreme conditions of a geothermal lake.
Contagious omicron strain replicates early in infection
New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.
Valneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
Antibiotics can help some bacteria survive for longer
Scientists have found a surprising effect of some antibiotics on certain bacteria – that the drugs can sometimes benefit bacteria, helping them live longer.
Two new species of oil-forming yeast discovered
A research group has discovered two new species of oil-forming yeast in the soil of Shiga Prefecture in Japan. Their study also examines the relationship between the prefecture’s diverse climate and microbial ecology.
Scientists uncover new pathway of diatom-mediated calcification
Researchers have found that the photosynthesis of a common diatom can induce substantial aragonite precipitation from artificial/natural seawater under significantly lower supersaturation levels required for the precipitation of inorganic CaCO3.
Scientists probe amoeba that thrives at 125°F
Biologists study the mechanisms that have allowed microbial eukaryotes to thrive in the extreme conditions of a geothermal lake.
MEMCOM AWARDS 2023
The Microbiologist has been shortlisted for the MEMCOM award for Best Magazine Launch or Re-launch. Subscribe now to make sure you don't miss out on the latest news, features, careers and opinion.
Subscribe
Valneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
TeselaGen Biotechnology renews partnership with Joint BioEnergy Institute
TeselaGen Biotechnology has announced that it is extending its relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract.
NICER than CRISPR: new gene editor reduces unintended mutations
Researchers led by Osaka University develop a new gene modification technique known as NICER that significantly reduces off-target mutations in DNA.
Researchers pioneer safe chemotherapy methods for treating bacterial infections
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow.
New vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
Nanoparticles made from plant viruses could be farmers’ new ally
Engineers have developed nanoparticles, fashioned from plant viruses, that can deliver pesticide molecules to soil depths that were previously unreachable.
TeselaGen Biotechnology renews partnership with Joint BioEnergy Institute
TeselaGen Biotechnology has announced that it is extending its relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract.
Lumen Bioscience wins historic $1.5 million Wilkes Center Climate Prize
The Seattle-based biotech company has developed a natural solution to eliminate the microorganisms in the cow gut that produces methane gas, a major cause of global warming.
Clinical trial of HIV vaccine begins in United States and South Africa
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people.
